Cargando…

Efectividad de mepolizumab y benralizumab en una cohorte de pacientes con asma grave eosinofílico en vida real

INTRODUCTION: Mepolizumab is a monoclonal antibody that inhibits circulating interleukin 5 (IL-5). Benralizumab binds to the alpha subunit of the IL-5 receptor, inducing the direct elimination of eosinophils and basophils. The aim of this study was to evaluate their effectiveness in our routine clin...

Descripción completa

Detalles Bibliográficos
Autores principales: Espinosa de los Monteros Garde, María José, Romero Sanz, Víctor, Blázquez Romero, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10369559/
https://www.ncbi.nlm.nih.gov/pubmed/37497072
http://dx.doi.org/10.1016/j.opresp.2021.100103